Clinical trial · Observational
Diffusion-tensor Imaging in Brain Tumors Evaluation
Contribution of Diffusion Tensor Imaging and Tractography in Primary and Secondary Brain Tumors Evaluation
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Primary and secondary brain tumors are challenging pathologies regarding diagnosis and treatment. MRI is widely used in the imaging evaluation and surgical planning, due to its spatial resolution and ability of tissular characterization. In this study patients with suspected brain tumors, confirmed by routine MRI evaluation (T1, T2, T2\*, FLAIR, T1 with contrast sequences) will undergo DWI and DTI evaluation. By analyzing collected data from MRI evaluation and patient records regarding surgical and histopathological data our aim is to investigate derived imaging biomarkers with impact in the surgical planning and rehabilitation of the patients.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Diffusion Tensor Imaging | — | UNRESOLVED | — |
| MRI | — | UNRESOLVED | — |
| Tractography | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| MRI | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Patients with primary brain tumors
- interventionNames
- Diagnostic Test: MRI
- label
- Patients with secondary brain tumors
- interventionNames
- Diagnostic Test: MRI
Primary outcomes (1)
- measure
- Tract damage
- timeFrame
- 3 months
- description
- Assess the damage of tracts at baseline preoperative
Secondary outcomes (1)
- measure
- Craniotomy size
- timeFrame
- 3 months
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * brain tumors confirmed by routine MRI evaluation * surgical treatment with histopathological diagnosis Exclusion Criteria: * MRI contraindications * past or present neurological or neurosurgical condition, beside the tumor * pregnancy
References
Publications (0)
Data not yet available